XETRA - Delayed Quote EUR

Bayer Aktiengesellschaft (BAYN.DE)

25.47

+1.41

+(5.84%)

As of 2:16:22 PM GMT+2. Market Open.

Bayer Shares Jump After Results Beat Expectations on Pharma Strength

Bayer shares jumped after the company reported better-than-expected sales and adjusted earnings for the first quarter, with cost-cutting and demand for kidney and cancer drugs boosting its pharmaceutical business.

The Wall Street Journal 4 hours ago

BAYRY

BAYZF
Georgia becomes second US state to shield maker of Roundup weed killer from some cancer claims

In a victory for global agrochemical maker Bayer, Georgia has become the second state to shield pesticide manufacturers from some lawsuits claiming that they failed to warn customers of potential dangers. The legislation signed Friday by Georgia Gov. Brian Kemp is designed to protect Bayer from lawsuits claiming that it failed to tell customers that its popular weed killer Roundup could cause cancer. It's written broadly enough to provide legal protection in Georgia to any pesticide manufacturer that follows federal labeling requirements.

Associated Press Finance 20 hours ago

BAYN.DE
+5.84%
Are Medical Stocks Lagging Bayer (BAYRY) This Year?

Here is how Bayer Aktiengesellschaft (BAYRY) and Boston Scientific (BSX) have performed compared to their sector so far this year.

Zacks 22 hours ago

BAYN.DE
+5.84%

BSX
Bayer to Slash Hundreds of Jobs in Crop Division Overhaul

The company said it will discontinue certain production activities at its Dormagen and Frankfurt am Main sites.

The Wall Street Journal 23 hours ago

BAYRY

BAYZF
Bayer to exit US seed treatment equipment business, email says

Bayer is exiting the seed treatment equipment business in the United States to help the company's finances, according to an email sent to customers that was seen by Reuters on Wednesday. A spokesperson confirmed that Bayer was exiting the business, which manufactured equipment involved in the process of treating farm seeds with products like fungicides and insecticides before planting in efforts to protect crop yields. It added that Bayer decided to direct resources toward primary areas of strength in crop protection products.

Reuters 12 days ago

BAYN.DE
+5.84%
Regeneron Stock Falls on Q1 Earnings and Sales Miss, Eylea Sales Down

REGN reports lower-than-expected Q1 results. Lead drug Eylea sales plunge in the United States due to competition. Stock down.

Zacks 13 days ago

REGN

SNY

BAYN.DE
+5.84%
North Dakota enacts nation's first law shielding Roundup's maker from some cancer lawsuits

A new first-of-its-kind law enacted in North Dakota could shield agrochemical manufacturer Bayer from lawsuits claiming it failed to warn customers that its popular weedkiller Roundup could cause cancer. The next state to follow North Dakota could be Georgia, where a similar bill is pending before Gov. Brian Kemp. Bayer, based in Germany, acquired Roundup with the 2018 purchase of St. Louis-based Monsanto.

Associated Press Finance 18 days ago

BAYN.DE
+5.84%
World Bank adds Bayer, Hyatt and other CEOs to private sector initiative

WASHINGTON (Reuters) -The World Bank on Wednesday added four top executives, including Bayer AG CEO Bill Anderson and Hyatt Hotels CEO Mark Hoplamazian, to an initiative working to address barriers to private sector investment in developing countries. World Bank President Ajay Banga, former CEO of Mastercard, launched the Private Sector Investment Lab shortly after taking office in June 2023, assembling 15 business leaders to brainstorm ways to create more jobs in developing countries.

Reuters 19 days ago

BAYN.DE
+5.84%
ConcertAI and Bayer to boost precision oncology with AI and ML insights

Translational360 is a recently introduced integrated research-grade longitudinal clinical molecular database.

Pharmaceutical Technology 20 days ago

BAYN.DE
+5.84%
Farmers’ Favorite Weedkiller Nears Its End, Bayer Warns

Pharmaceutical and agriculture conglomerate Bayer said it could stop producing the world’s most popular weedkiller, unless it gets court protection against lawsuits blaming the herbicide for causing cancer. Roundup has generated tens of billions of dollars in sales over time for Bayer and Monsanto, the biotech seed giant and developer of Roundup that Bayer acquired in 2018. Bayer currently produces about 40% of the world’s glyphosate, which farmers spray across fields to tame crop-threatening weeds.

The Wall Street Journal 28 days ago

BAYRY

BAYZF
Bayer Obtains Full FDA Approval for Oncology Drug Vitrakvi

The FDA converts its accelerated approval to full approval for BAYRY's oncology drug, Vitrakvi, on positive data from confirmatory studies.

Zacks last month

BAYN.DE
+5.84%
FDA Grants Complete Approval To Bayer's Drug For Certain Type Cancer With Mutation

The U.S. Food And Drug Administration (FDA) granted full approval to Bayer AG’s (OTC:BAYRY) Vitrakvi (larotrectinib) for adult and pediatric patients with solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion. Vitrakvi has demonstrated clinically meaningful and durable responses across various NTRK fusion-positive solid tumors. FDA first granted Vitrakvi accelerated approval in November 2018. The approval is based on data from three multicenter, open-label, single-arm

Benzinga last month

BAYN.DE
+5.84%
Trending tickers: TSMC, Trump Media, US Steel, Novo Nordisk and Tesco

The latest investor updates on stocks that are trending on Thursday.

Yahoo Finance UK last month

STZ

^DJI

TSM
Trending tickers: Apple, Advanced Micro Devices, Ford, BP and AstraZeneca

The latest investor updates on stocks that are trending on Wednesday.

Yahoo Finance UK last month

DAL

GM

SVNDF
Bayer's Vividion Initiates Dosing in Early-Stage Cancer Study

BAYRY subsidiary Vividion Therapeutics doses the first patient in a phase I study on VVD-159642 to treat advanced solid tumors.

Zacks last month

BAYN.DE
+5.84%
J&J's Third Bankruptcy Attempt to End Talc Suits Rejected

J&J fails in its third attempt to settle tens of thousands of lawsuits claiming its talc-based powder caused cancer.

Zacks last month

JNJ

BAYN.DE
+5.84%
Bayer Licenses PRMT5 inhibitor From Suzhou Puhe BioPharma

Bayer obtains an exclusive worldwide license for MTA-cooperative PRMT5 inhibitor from Suzhou Puhe BioPharma for selective targeting of MTAP-deleted tumors.

Zacks last month

BAYN.DE
+5.84%
Bayer (BAYRY) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Bayer (BAYRY) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Zacks last month

BAYN.DE
+5.84%
Bayer Down on Verdict to Pay $2.1B to Plaintiff in Roundup Litigation

BAYRY suffers a setback after the jury at the Barnes Roundup trial in the State Court of Cobb County, Georgia, reached a verdict in favor of the plaintiff. Stock declines.

Zacks last month

BAYN.DE
+5.84%
5 Large Drug Stocks to Watch as Industry Recovers

R&D innovation is likely to remain a major focus area in 2025. In the Large-Cap Pharmaceuticals industry, AbbVie (ABBV), Novo Nordisk (NVO), Novartis (NVS), Pfizer (PFE) and Bayer (BAYRY) are worth retaining in one's portfolio

Zacks last month

ABBV

PFE

NVS

Performance Overview

Return	BAYN.DE	DAX P (^GDAXI)
YTD	+32.48%	+18.40%
1-Year	-12.91%	+25.77%
3-Year	-55.69%	+68.04%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Bayer Aktiengesellschaft (BAYN.DE)

Bayer Shares Jump After Results Beat Expectations on Pharma Strength

Georgia becomes second US state to shield maker of Roundup weed killer from some cancer claims

Are Medical Stocks Lagging Bayer (BAYRY) This Year?

Bayer to Slash Hundreds of Jobs in Crop Division Overhaul

Bayer to exit US seed treatment equipment business, email says

Regeneron Stock Falls on Q1 Earnings and Sales Miss, Eylea Sales Down

North Dakota enacts nation's first law shielding Roundup's maker from some cancer lawsuits

World Bank adds Bayer, Hyatt and other CEOs to private sector initiative

ConcertAI and Bayer to boost precision oncology with AI and ML insights

Farmers’ Favorite Weedkiller Nears Its End, Bayer Warns

Bayer Obtains Full FDA Approval for Oncology Drug Vitrakvi

FDA Grants Complete Approval To Bayer's Drug For Certain Type Cancer With Mutation

Trending tickers: TSMC, Trump Media, US Steel, Novo Nordisk and Tesco

Trending tickers: Apple, Advanced Micro Devices, Ford, BP and AstraZeneca

Bayer's Vividion Initiates Dosing in Early-Stage Cancer Study

J&J's Third Bankruptcy Attempt to End Talc Suits Rejected

Bayer Licenses PRMT5 inhibitor From Suzhou Puhe BioPharma

Bayer (BAYRY) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Bayer Down on Verdict to Pay $2.1B to Plaintiff in Roundup Litigation

5 Large Drug Stocks to Watch as Industry Recovers

Performance Overview